In a murine model of NAFLD, high-fat-diet-induced steatosis was ameliorated through pioglitazone administration by PPARγ- and PPARα-dependent increases of lipolysis, β-oxidation, and autophagy [110]. The gene discussed is PPARG; the disease is metabolic dysfunction-associated steatotic liver disease.